Merck & Co., Inc. (MRK) News Today → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free MRK Stock Alerts $126.88 -0.06 (-0.05%) (As of 03:04 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck & Co., Inc. (NYSE:MRK) Shares Sold by Demars Financial Group LLCmarketbeat.com - April 23 at 2:36 PMHere’s Why Merck & Co. (MRK) Outperformed in Q1finance.yahoo.com - April 23 at 11:09 AMMerck & Co., Inc. (NYSE:MRK) Expected to Earn Q4 2025 Earnings of $2.39 Per Sharemarketbeat.com - April 23 at 6:31 AMIllinois Municipal Retirement Fund Has $51.80 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 22 at 9:59 PMQ3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)americanbankingnews.com - April 22 at 1:52 AMFoundry Partners LLC Lowers Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 21 at 10:35 PMCwm LLC Acquires 6,969 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 8:22 PMMerck & Co., Inc. (NYSE:MRK) Stock Rating Reaffirmed by Cantor Fitzgeraldamericanbankingnews.com - April 20 at 5:16 AMJ.W. Cole Advisors Inc. Acquires 8,241 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 12:54 AMCramer's week ahead: Earnings from Tesla, Merck and Big Techcnbc.com - April 19 at 7:33 PMHealth Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapyfinance.yahoo.com - April 19 at 7:38 AMMerck & Co., Inc. (NYSE:MRK) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 19 at 4:46 AMMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Fidelis Capital Partners LLCmarketbeat.com - April 18 at 7:04 PMCantor Fitzgerald Reiterates Overweight Rating for Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 18 at 10:35 AMMerck & Co., Inc. (MRK) Set to Announce Earnings on Thursdayamericanbankingnews.com - April 18 at 1:08 AMDaiwa Securities Group Inc. Has $34.99 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 17 at 6:51 PMMerck Earnings Preview: Not Much To Fear, Plenty To Look Forward Toseekingalpha.com - April 17 at 3:52 PMWant $2000 In Passive Income? Invest $1000 Into These Dividend Stocks247wallst.com - April 17 at 9:35 AMMerck Insiders Sold US$15m Of Shares Suggesting Hesitancyfinance.yahoo.com - April 17 at 8:09 AMComing FDA Approvals Could Send These 3 Drug Stocks Soaringinvestorplace.com - April 17 at 8:00 AM6 Gold Standard Dividend Stocks Passive Income Investors Need to Buy247wallst.com - April 17 at 7:58 AMZurcher Kantonalbank Zurich Cantonalbank Purchases 50,423 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 16 at 5:21 PM3 Dow Stocks to Buy Now: Q2 Editioninvestorplace.com - April 16 at 3:17 PMMerck & Co., Inc. (NYSE:MRK) Holdings Reduced by Donaldson Capital Management LLCmarketbeat.com - April 15 at 5:37 PMBetter Growth Play: Merck or The Vanguard Growth Index Fund?fool.com - April 15 at 9:00 AMMerck & Co., Inc. (NYSE:MRK) Holdings Decreased by Harel Insurance Investments & Financial Services Ltd.marketbeat.com - April 15 at 8:52 AMWaldron Private Wealth LLC Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 14 at 7:09 PMMn Services Vermogensbeheer B.V. Has $131.22 Million Stake in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 13 at 7:12 PMIngalls & Snyder LLC Sells 12,001 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 12 at 11:45 PMUS biopharma first quarter earnings seen stable amid low expectationsproactiveinvestors.com - April 12 at 11:47 AM1 New Green Flag for Moderna and Merck Stockfool.com - April 12 at 8:45 AMMerck & Co., Inc. (NYSE:MRK) Shares Acquired by Perigon Wealth Management LLCmarketbeat.com - April 11 at 7:31 PM19,528 Shares in Merck & Co., Inc. (NYSE:MRK) Purchased by Sutton Place Investors LLCmarketbeat.com - April 11 at 2:31 PMMerck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?finance.yahoo.com - April 11 at 12:59 PMValue Partners Investments Inc. Purchases 21,482 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 10 at 12:47 PMCompany News for Apr 10, 2024msn.com - April 10 at 10:51 AMMerck & Co., Inc. (NYSE:MRK) Shares Acquired by Impax Asset Management Group plcmarketbeat.com - April 9 at 6:39 PMInvestment Partners Asset Management Inc. Makes New Investment in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 8 at 10:18 AMMerck & Co., Inc. (NYSE:MRK) PT Raised to $143.00marketbeat.com - April 8 at 8:29 AMWoodard & Co. Asset Management Group Inc. ADV Has $1.30 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 7 at 3:37 PMThe 3 Most Undervalued S&P 500 Stocks to Buy in April 2024investorplace.com - April 7 at 2:00 PMMirae Asset Global Investments Co. Ltd. Acquires 29,493 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 6 at 12:37 PMMerck & Co., Inc. (NYSE:MRK) Shares Sold by ANTIPODES PARTNERS Ltdmarketbeat.com - April 5 at 4:42 PMBoston Trust Walden Corp Has $83.74 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 4 at 11:22 PMMarket Whales and Their Recent Bets on MRK Optionsbenzinga.com - April 4 at 7:46 PMMerck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancerbusinesswire.com - April 4 at 6:45 AMSmallwood Wealth Investment Management LLC Sells 14,254 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 3 at 7:33 PMMerck (MRK) Stock Sinks As Market Gains: What You Should Knowmsn.com - April 3 at 7:03 PMMerck: We Were Wrong, But The Exuberance Is Overly Done Here (Rating Upgrade)seekingalpha.com - April 3 at 2:03 PMMerck Foundation Announced "Diabetes and Hypertension" Media Recognition Awards 2024 for Latin American Countriesbusinesswire.com - April 3 at 10:48 AM Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼1.000.46▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼2615▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AbbVie News Johnson & Johnson News Pfizer News Bristol-Myers Squibb News Eli Lilly and Company News AstraZeneca News Novartis News Abbott Laboratories News Sanofi News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
